ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by ARYA Sciences Management, a life sciences-focused SPAC platform that has launched multiple acquisition vehicles targeting the healthcare and biotechnology sectors. ARYD completed its initial public offering in 2021 and filed a Form 10-Q with the Securities and Exchange Commission on May 13, 2021, reflecting its status as a company actively searching for a qualifying business combination at that time. The ARYA Sciences franchise has a track record of bringing therapeutics and life sciences companies to public markets through the SPAC structure. To access full filing history, deal status updates, and institutional data on ARYD, sign up for complete access at SpacDesk.